Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global RSV Diagnostics Market Outlook

The global RSV diagnostics market attained a value of about USD 1028.55 million in 2023. The market is further expected to grow at a CAGR of 10.2% during the forecast period of 2024-2032 to reach nearly USD 2465.26 million by 2032.

The Increasing Prevalence of RSV Disease Invigorating the Market Growth of RSV Diagnostics

The global market for RSV diagnostics is being driven by the increasing prevalence of RSV disorder, especially among children below the age of two years. The respiratory syncytial virus is a common and contagious virus that infects the respiratory tract causing breathing problems. Factors such as increasing investments into healthcare infrastructure in conjunction with the rising focus of parents on child medical care are positively impacting the growth of the market.

Global RSV Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

As the symptoms of RSV are similar to other respiratory disorders, the need for rapid, specific, and effective diagnostics is invigorating the growth of the market. Furthermore, the increasing awareness regarding the high survival rates after early diagnosis and the easy availability of diagnostics modalities are further positively influencing the overall market growth of RSV diagnostics. The market is further augmented by favourable government measures, such as reimbursement policies, awareness camps, and free diagnostics, among others.

RSV Diagnostics Market Segmentation

Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which causes asthma, pneumonia, middle ear infections, and sometimes death if left untreated. The diagnostics methods for RSV include blood tests, chest x-rays, checking for white blood cell (WBC) and oxygen levels in the blood, and swab secretions.

Global RSV Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

On the basis of product, the market can be divided into:

  • Direct Fluorescent Antibody (DFA) Method
  • Rapid Antigen Diagnostic Test (RADT) 
  • Molecular Diagnostics
  • Chromatographic Immunoassay
  • Diagnostic Imaging 
  • Gel Microdroplets
  • Flow Cytometry
  • Others

Chromatographic immunoassay can be further divided into gravity driven test and oligochromatography.

Based on end-use, the market can be segmented into:

  • Hospitals
  • Laboratory
  • Clinics 
  • Homecare

The EMR report looks into the regional markets of RSV diagnostics like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

Improved Healthcare Technologies to Propel the Market Growth of RSV Diagnostics

The growth in the global market of RSV diagnostics is expected to be driven by the advent of advanced techniques, including bio-and nanotechnology facilitating the development of modern detection systems for RSV, such as western bolt, enzyme linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). In addition, the nucleic acid amplification techniques and loop-mediated isothermal amplification aligned with point of care (POC) devices are expected to augment the growth of the market in the coming years by allowing testing to be performed using a one-step kit requiring only the addition of a patient sample. In addition to this, fast approvals by the FDA, government and private funding into the healthcare structure, and robust investments into the research and development (R&D) programmes are further expected to drive the market growth of RSV diagnostics over the forecast period.

Global RSV Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Global RSV Diagnostics Market

The report presents a detailed analysis of the following key players in the global RSV diagnostics market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • bioMérieux SA
  • DiaSorin Molecular LLC
  • Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • End-Use
  • Region
Breakup by Product
  • Direct Fluorescent Antibody (DFA) Method
  • Rapid Antigen Diagnostic Test (RADT)
  • Molecular Diagnostics
  • Chromatographic Immunoassay
  • Diagnostic Imaging
  • Gel Microdroplets
  • Flow Cytometry
  • Others
Breakup by End-Use
  • Hospitals
  • Laboratory
  • Clinics
  • Homecare
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • bioMérieux SA
  • DiaSorin Molecular LLC
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The global RSV diagnostics market attained a value of nearly USD 1028.55 million in 2023.

The market is projected to grow at a CAGR of 10.2% in the forecast period of 2024-2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 2465.26 million by 2032.

The market is being driven by the rising prevalence of RSV disorder, especially amongst children below the age of two and the resultant requirement for an effective diagnostic solution.

Improvements in diagnostics technology and robust investments into the research and development (R&D) activities are expected to aid the market growth in the coming years.

The major regional markets for RSV diagnostics are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

The major products of RSV diagnostics are direct fluorescent antibody (DFA) method, rapid antigen diagnostic test  (RADT), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, and flow cytometry, among others.

The major end-uses of RSV diagnostics are hospitals, laboratory, clinics, and homecare.

The major players in the industry are Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, bioMérieux SA, and DiaSorin Molecular LLC, among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124